Discrete vulnerability to pharmacological CDK2 inhibition is governed by heterogeneity of the cancer cell cycle
癌细胞周期的异质性决定了药物 CDK2 抑制的敏感性
期刊:Nature Communications
影响因子:14.7
doi:10.1038/s41467-025-56674-4
Vishnu Kumarasamy, Jianxin Wang, Michelle Roti, Yin Wan, Adam P Dommer, Hanna Rosenheck, Sivasankar Putta, Alec Trub, John Bisi, Jay Strum, Patrick Roberts, Seth M Rubin, Costakis Frangou, Karen McLean, Agnieszka K Witkiewicz, Erik S Knudsen